Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohan Hingorani

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Proceedings of the Nutrition Society|January 6, 2023
Physical activity and dietary considerations for prostate cancer patients: future research directionsAndrew J Hamblen, James W Bray, Mohan Hingorani, et al.
Cancer Biology & Medicine|April 11, 2015
Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-resistant prostate cancer treated with systemic therapy (chemotherapy or abiraterone)?-a report of three casesMohan Hingorani, Sanjay Dixit, Pattu Pugazhenthi, et al.
Cancer Biology & Medicine|January 23, 2015
Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reportsMohan Hingorani, Sanjay Dixit, Fahim Bashir, et al.
Brachytherapy|September 24, 2023
Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancerChristopher M Jones, Annabel Lyles, Peter Bownes, et al.
Current Cancer Drug Targets|March 6, 2010
The biology of the sodium iodide symporter and its potential for targeted gene deliveryMohan Hingorani, Christine Spitzweg, Georges Vassaux, et al.
Oncology|April 4, 2023
Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment AlgorithmMohan Hingorani, Rebecca Goody, Georgios Bozas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2009
Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidityPaul Hatfield, Mohan Hingorani, Ganesh Radhakrishna, et al.
Cancer Research and Treatment|February 18, 2015
Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric CancerMohan Hingorani, Sanjay Dixit, Miriam Johnson, et al.
The British Journal of Radiology|January 30, 2018
Management of elderly patients with glioblastoma-multiforme-a systematic reviewAlmadani Asmaa, Sanjay Dixit, Chris Rowland-Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporterInge Peerlinck, Andrew Merron, Patrick Baril, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Proceedings of the Nutrition Society|January 6, 2023
Physical activity and dietary considerations for prostate cancer patients: future research directionsAndrew J Hamblen, James W Bray, Mohan Hingorani, et al.
Cancer Biology & Medicine|April 11, 2015
Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-resistant prostate cancer treated with systemic therapy (chemotherapy or abiraterone)?-a report of three casesMohan Hingorani, Sanjay Dixit, Pattu Pugazhenthi, et al.
Cancer Biology & Medicine|January 23, 2015
Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reportsMohan Hingorani, Sanjay Dixit, Fahim Bashir, et al.
Brachytherapy|September 24, 2023
Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancerChristopher M Jones, Annabel Lyles, Peter Bownes, et al.
Current Cancer Drug Targets|March 6, 2010
The biology of the sodium iodide symporter and its potential for targeted gene deliveryMohan Hingorani, Christine Spitzweg, Georges Vassaux, et al.
Oncology|April 4, 2023
Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment AlgorithmMohan Hingorani, Rebecca Goody, Georgios Bozas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2009
Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidityPaul Hatfield, Mohan Hingorani, Ganesh Radhakrishna, et al.
Cancer Research and Treatment|February 18, 2015
Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric CancerMohan Hingorani, Sanjay Dixit, Miriam Johnson, et al.
The British Journal of Radiology|January 30, 2018
Management of elderly patients with glioblastoma-multiforme-a systematic reviewAlmadani Asmaa, Sanjay Dixit, Chris Rowland-Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporterInge Peerlinck, Andrew Merron, Patrick Baril, et al.
Pageof 3